Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers are commonly
prescribed for the management of hypertension. In addition, each of these drug classes has …

The chemistry, pharmacology, pharmacokinetics, adverse effects, and dosages of the three
currently available angiotensin-converting enzyme (ACE) inhibitors are reviewed. This class …

Conclusions Obviously, the introduction of new antihypertensive drugs, as promising they
may ever be, will by itself not lead to an improvement of the overall quality of hypertension …

The provocative editorial by Verma and Strauss in the BMJ 5 years ago1 stating that
angiotensin receptor blockers (ARBs)'may increase myocardial infarction—and patients may …

With the fanfare associated with the introduction of angiotensin II receptor blockers (ARBs) 6
years ago, there was an immediate assumption that they would replace the angiotensin …

This review discusses important issues related to the use of angiotensin-converting enzyme
inhibitors (ACEIs). ACEIs have been shown in clinical trials to slow progressive renal …

BACKGROUND: Efficacy of blood pressure (BP) lowering may differ between clinical trials
and what is observed in clinical practice. These differences may contribute to poor BP …

Angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs)
are widely used in the treatment of hypertension, chronic kidney disease, and heart failure …

Objectives: Identify the mechanism of action of ACE inhibitors. Summarize monitoring/follow-
up for patients initiated on ACE inhibitor therapy. Review the dosing parameters adjusting or …

Ma anipulation of the renin-angiotensin system has evolved during the last few years from
an obscure line of biochemical research and pathophysiologic experimentation into a new …